HIMS vs. NVO
HIMS (Hims & Hers Health, Inc.) and NVO (Novo Nordisk A/S) are both stocks. HIMS operates in Household & Personal Products (Consumer Defensive), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, HIMS returned 15.10%/yr vs 1.78%/yr for NVO. At a 0.17 correlation, their price movements are largely independent.
Performance
HIMS vs. NVO - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with HIMS having a -16.32% return and NVO slightly lower at -16.56%.
HIMS
- 1D
- 3.74%
- 1M
- -3.89%
- YTD
- -16.32%
- 6M
- -30.55%
- 1Y
- -51.77%
- 3Y*
- 44.53%
- 5Y*
- 15.10%
- 10Y*
- —
NVO
- 1D
- -4.52%
- 1M
- -10.96%
- YTD
- -16.56%
- 6M
- -9.23%
- 1Y
- -42.47%
- 3Y*
- -17.53%
- 5Y*
- 1.78%
- 10Y*
- 6.20%
HIMS vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
HIMS Hims & Hers Health, Inc. | -16.32% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.02% |
NVO Novo Nordisk A/S | -16.56% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 16.93% |
Correlation
The correlation between HIMS and NVO is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Sep 16, 2019 | 0.17 |
Fundamentals
HIMS:
$6.20B
NVO:
$182.49B
HIMS:
-$0.05
NVO:
$27.42
HIMS:
2.81
NVO:
0.56
HIMS:
13.91
NVO:
0.90
HIMS:
$2.37B
NVO:
$327.80B
HIMS:
$1.70B
NVO:
$268.30B
HIMS:
$16.04M
NVO:
$181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HIMS vs. NVO — Risk / Return Rank
HIMS
NVO
HIMS vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HIMS | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.28 | ||
| Sortino ratioReturn per unit of downside risk | +0.59 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 0.86 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | -0.77 | +0.11 |
| Martin ratioReturn relative to average drawdown | -1.09 | -1.14 | +0.05 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HIMS | NVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.54 | -0.82 | +0.28 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | 0.05 | +0.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.19 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.47 | -0.26 |
Drawdowns
HIMS vs. NVO - Drawdown Comparison
The maximum HIMS drawdown since its inception was -87.29%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for HIMS and NVO.
Loading charts...
Drawdown Indicators
| HIMS | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.29% | -74.70% | -12.59% |
Max Drawdown (1Y)Largest decline over 1 year | -78.06% | -55.03% | -23.03% |
Max Drawdown (3Y)Largest decline over 3 years | -78.88% | -74.70% | -4.18% |
Max Drawdown (5Y)Largest decline over 5 years | -78.88% | -74.70% | -4.18% |
Max Drawdown (10Y)Largest decline over 10 years | — | -74.70% | — |
Current DrawdownCurrent decline from peak | -60.47% | -70.19% | +9.72% |
Average DrawdownAverage peak-to-trough decline | -43.22% | -17.77% | -25.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.51% | 37.21% | +10.30% |
Volatility
HIMS vs. NVO - Volatility Comparison
Hims & Hers Health, Inc. (HIMS) has a higher volatility of 26.28% compared to Novo Nordisk A/S (NVO) at 9.75%. This indicates that HIMS's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HIMS | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.28% | 9.75% | +16.53% |
Volatility (6M)Calculated over the trailing 6-month period | 66.46% | 38.30% | +28.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 96.13% | 52.08% | +44.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.39% | 38.31% | +45.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.19% | 32.56% | +44.63% |
Dividends
HIMS vs. NVO - Dividend Comparison
HIMS has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.39%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIMS Hims & Hers Health, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 4.39% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
HIMS vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Hims & Hers Health, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HIMS vs. NVO - Profitability Comparison
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
HIMS and NVO have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (26.28%) compared to NVO (9.75%). In terms of maximum drawdown, HIMS dropped -87.29% vs NVO's -74.70%.
HIMS currently has the higher Sharpe Ratio (-0.54 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HIMS and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer